Literature DB >> 19603178

Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases.

Alexa Klettner1, Johann Roider.   

Abstract

PURPOSE: Vascular endothelial growth factor (VEGF) is a fundamental factor for angiogenesis. It plays important roles in pathological conditions (e.g. the development of wet AMD), but also in the healthy organism) e.g. in maintaining the vasculature and supporting the retina). Recent therapies to treat the wet AMD focus on neutralizing VEGF indiscriminately. VEGF is constitutively expressed in the retina, but its expression is upregulated by various (noxious) stimuli, e.g. oxidative stress or hypoxia. Discrimination between constitutive expression of VEGF and its pathological upregulation might provide the possibility of focusing on inhibiting the pathological expression only. Here, we focused on the influence of different mitogen-activated protein kinase (MAPK) (p38, Erk, JNK) on the secretion and expression of VEGF, with or without being challenged by oxidative stress.
METHODS: VEGF secretion was measured using a perfusion organ culture model; expression was examined in primary RPE culture and Western blotting.
RESULTS: Constitutive VEGF expression and secretion can be diminished by inhibiting p38, while inhibiting Erk or JNK does not show a significant effect. When challenged with oxidative stress (250 microM t-butylhydroperoxide), VEGF expression and secretion increases and the influence of the MAPK changes: While p38 still accounts for about 30% of the secretion, Erk shows a similar influence. Inhibiting JNK presents conflicting results. In organ culture, inhibiting JNK significantly increases VEGF secretion after stimulation with 250 microM tBH, while with regard to VEGF expression in RPE cell culture, this effect could not be seen.
CONCLUSION: Constitutive and oxidative stress induced VEGF secretion, and expression is differently regulated, which might offer an opportunity to selectively inhibit pathological VEGF expression only.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19603178     DOI: 10.1007/s00417-009-1139-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  p38 Mitogen-activated protein kinase mediates hypoxia-induced vascular endothelial growth factor release in human endothelial cells.

Authors:  Bei Fan; Yan-Xia Wang; Tai Yao; Yi-Chun Zhu
Journal:  Sheng Li Xue Bao       Date:  2005-02-25

2.  p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts.

Authors:  J Milanini; F Viñals; J Pouysségur; G Pagès
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

3.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

Authors:  Vassiliki Poulaki; Wenying Qin; Antonia M Joussen; Peter Hurlbut; Stanley J Wiegand; John Rudge; George D Yancopoulos; Anthony P Adamis
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

4.  Regulation of vascular endothelial growth factor expression by advanced glycation end products.

Authors:  C Treins; S Giorgetti-Peraldi; J Murdaca; E Van Obberghen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

5.  MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF.

Authors:  A Sodhi; S Montaner; H Miyazaki; J S Gutkind
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

6.  Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.

Authors:  Denise Hilfiker-Kleiner; Andres Hilfiker; Karol Kaminski; Arnd Schaefer; Joon-Keun Park; Kim Michel; Anja Quint; Moshe Yaniv; Jonathan B Weitzman; Helmut Drexler
Journal:  Circulation       Date:  2005-08-29       Impact factor: 29.690

Review 7.  Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

Authors:  Ruth B Caldwell; Manuela Bartoli; M Ali Behzadian; Azza E B El-Remessy; Mohamed Al-Shabrawey; Daniel H Platt; Gregory I Liou; R William Caldwell
Journal:  Curr Drug Targets       Date:  2005-06       Impact factor: 3.465

8.  The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock response.

Authors:  Alexa Klettner; Thomas Herdegen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

9.  JunD reduces tumor angiogenesis by protecting cells from oxidative stress.

Authors:  Damien Gerald; Edurne Berra; Yves M Frapart; Denise A Chan; Amato J Giaccia; Daniel Mansuy; Jacques Pouysségur; Moshe Yaniv; Fatima Mechta-Grigoriou
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

10.  Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.

Authors:  Swaantje Peters; Peter Heiduschka; Sylvie Julien; Focke Ziemssen; Heike Fietz; Karl Ulrich Bartz-Schmidt; Ulrich Schraermeyer
Journal:  Am J Ophthalmol       Date:  2007-04-23       Impact factor: 5.258

View more
  30 in total

1.  Bridging the gap between traditional cell cultures and bioreactors applied in regenerative medicine: practical experiences with the MINUSHEET perfusion culture system.

Authors:  Will W Minuth; Lucia Denk
Journal:  Cytotechnology       Date:  2015-04-17       Impact factor: 2.058

Review 2.  Age-Related Macular Degeneration and Intracrine Biology: An Hypothesis.

Authors:  Richard N Re
Journal:  Ochsner J       Date:  2016

3.  NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration.

Authors:  Alexander G Marneros
Journal:  Cell Rep       Date:  2013-09-05       Impact factor: 9.423

4.  Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers.

Authors:  Kannan Kunchithapautham; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases.

Authors:  Hendrik Faby; Jost Hillenkamp; Johann Roider; Alexa Klettner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-22       Impact factor: 3.117

6.  Lysosomal stress and lipid peroxidation products induce VEGF-121 and VEGF-165 expression in ARPE-19 cells.

Authors:  Marion Bergmann; Frank Holz; Jürgen Kopitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-21       Impact factor: 3.117

7.  Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.

Authors:  Zsolt Ablonczy; Mohammad Dahrouj; Alexander G Marneros
Journal:  FASEB J       Date:  2014-02-20       Impact factor: 5.191

Review 8.  Oxidative and Nitrosative Stress in Age-Related Macular Degeneration: A Review of Their Role in Different Stages of Disease.

Authors:  Caterina Toma; Stefano De Cillà; Aurelio Palumbo; Divya Praveen Garhwal; Elena Grossini
Journal:  Antioxidants (Basel)       Date:  2021-04-23

9.  Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway.

Authors:  Alexa Klettner; Daniel Westhues; Jens Lassen; Sofia Bartsch; Johann Roider
Journal:  Mol Vis       Date:  2013-01-03       Impact factor: 2.367

10.  Supportive development of functional tissues for biomedical research using the MINUSHEET® perfusion system.

Authors:  Will W Minuth; Lucia Denk
Journal:  Clin Transl Med       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.